HESTERBIO2,270.00

Hester Biosciences Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersWINDLASSYNCOMFNGLFINEINDOCOSAIPARENTJAGSNPHARMPANACEABIOMcap ₹1,931 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations304.5311.1332.6325.7
Other Income10.63.99.79.0
Total Income315.2315.0342.3334.7
Expenses
+ Cost of Materials Consumed54.363.970.670.8
+ Purchases of Stock-in-Trade32.817.615.716.8
+ Changes in Inventories8.76.8-4.4-11.0
+ Employee Benefit Expense64.162.462.762.3
+ Finance Costs19.812.710.912.2
+ Depreciation & Amortisation17.216.818.921.7
+ Other Expenses90.999.3101.3100.3
Total Expenses287.8279.6275.8273.1
EBITDA53.761.186.786.6
EBIT36.544.367.864.9
Profit
PBT before Exceptional Items27.335.566.561.7
+ Exceptional Items0.00.02.988.3
Pretax Income27.335.569.5150.0
+ Current Tax10.712.215.117.5
+ Deferred Tax0.1-1.53.22.9
Tax Expense10.810.718.420.4
+ Share of Associates & JVs4.64.16.47.4
Net Income21.228.857.5136.9
+ Net Income — Continuing Ops16.624.751.1129.6
+ Other Comprehensive Income-0.00.1-2.3-2.6
Total Comprehensive Income21.128.955.2134.3
Net Income to Common18.927.555.6136.2
Minority Interest2.31.31.80.7
Per Share
Basic EPS24.8833.8967.57160.95
Diluted EPS24.8833.8967.57160.95
Other Comprehensive Income — detail
+ Other Comprehensive Income0.1-2.3-2.6
+ Items NOT to be Reclassified to P&L-0.1-0.5-0.0
+ Tax on Items NOT to be Reclassified-0.1-0.00.0
+ Tax on Items NOT to be Reclassified — alt tag-0.0
+ Items to be Reclassified to P&L0.00.5-2.3-2.7
Comprehensive Income — Owners of Parent18.90.153.3133.6
Comprehensive Income — Non-controlling Interests2.3-0.01.90.8
Per Share — as-filed variants
Basic EPS — Continuing Operations24.8833.8967.57160.95
Diluted EPS — Continuing Operations24.8833.8967.57160.95
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit208.7222.8250.6249.2
Gross Margin %68.5271.6175.3676.49
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)27.335.566.561.7
− Exceptional Items (reconciliation)0.00.02.988.3
Net Income Adj (tax-effected)21.228.855.360.6
EPS Adj24.8833.8965.0371.29
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital8.58.58.58.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.